LIPITOR CLONE
- Ranbaxy Laboratories falls on payment concerns to Teva Pharmaceuticals, delay in settlment with FDARanbaxy's share price fell 1.66% due to concerns about payment to Teva Pharmaceuticals and delay in settlement with US authorities.
- Ranbaxy Laboratories to roll out Lipitor Clone in US on Nov 30Following a settlement in 2008, Pfizer Inc gave Ranbaxy exclusive marketing rights to sell Lipitor's low-cost version for six months.
- Pfizer’s Wyeth bid may trigger rush for M&AsPfizer’s potential purchase of Wyeth for more than $60 billion may set off a rush to consolidate in an industry buffeted by a thinner pipel...
- Load More